ARRIVENT

pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer

new product commercialization services; new product commercialization services in the fields of pharmaceuticals and biotechnology

research and development in the pharmaceutical and biotechnology fields